Literature DB >> 17110659

An observation of interest relative to the practice of spectroscopic measurements in multiple sclerosis.

Ana Maria Pascual, Isabel Boscá, Bonaventura Casanova, M Carmen Martinez-Bisbal, Bernardo Celda, Francisco Coret, Luis Marti-Bonmati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17110659      PMCID： PMC7977236     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  6 in total

1.  Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.

Authors:  M C Tartaglia; S Narayanan; N De Stefano; R Arnaoutelis; S B Antel; S J Francis; A C Santos; Y Lapierre; D L Arnold
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

Review 2.  1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review.

Authors:  Zografos Caramanos; Sridar Narayanan; Douglas L Arnold
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

3.  MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Authors:  J P Ranjeva; J Pelletier; S Confort-Gouny; D Ibarrola; B Audoin; Y Le Fur; P Viout; A Ali Chérif; P J Cozzone
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

4.  Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model.

Authors:  M N Degaonkar; M Khubchandhani; J K Dhawan; R Jayasundar; N R Jagannathan
Journal:  NMR Biomed       Date:  2002-06       Impact factor: 4.044

5.  High resolution proton NMR spectroscopy of multiple sclerosis lesions.

Authors:  S E Davies; J Newcombe; S R Williams; W I McDonald; J B Clark
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

6.  Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study.

Authors:  B Casanova; M C Martínez-Bisbal; C Valero; B Celda; L Martí-Bonmatí; A Pascual; L Landente; F Coret
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.